Literature DB >> 28965872

Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Jennifer Zitser1, Chava Peretz2, Aya Ber David3, Herzl Shabtai3, Adi Ezra3, Meir Kestenbaum3, Marina Brozgol3, Alina Rosenberg2, Talia Herman3, Yakov Balash3, Avi Gadoth3, Avner Thaler4, Glenn T Stebbins5, Christopher G Goetz5, Barbara C Tilley6, Sheng T Luo6, Yuanyuan Liu6, Nir Giladi7, Tanya Gurevich7.   

Abstract

BACKGROUND: The Movement Disorders Society (MDS) published the English new Unified Parkinson's Disease Rating Scale (MDS-UPDRS) as the official benchmark scale for Parkinson's disease (PD) in 2008. We aimed to validate the Hebrew version of the MDS-UPDRS, explore its dimensionality and compare it to the original English one.
METHODS: The MDS-UPDRS questionnaire was translated to Hebrew and was tested on 389 patients with PD, treated at the Movement Disorders Unit at Tel-Aviv Medical Center. The MDS-UPDRS is made up of four sections. The higher the score, the worst the clinical situation of the patient is. Confirmatory and explanatory factor analysis were applied to determine if the factor structure of the English version could be confirmed in the Hebrew version.
RESULTS: The Hebrew version of the MDS-UPDRS showed satisfactory clinimetric properties. The internal consistency of the Hebrew-version was satisfactory, with Cronbach's alpha values 0.79, 0.90, 0.93, 0.80, for parts 1 to 4 respectively. In the confirmatory factor analysis, all four parts had high (greater than 0.90) comparative fit index (CFI) in comparison to the original English MDS-UPDRS with high factor structure (0.96, 0.99, 0.94, 1.00, respectively), thus confirming the pre-specified English factor structure. Explanatory factor analysis yielded that the Hebrew responses differed from the English one within an acceptable range: in isolated item differences in factor structure and in the findings of few items having cross loading on multiple factors.
CONCLUSIONS: The Hebrew version of the MDS-UPDRS meets the requirements to be designated as the Official Hebrew Version of the MDS-UPDRS.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clinimetrics; MDS-UPDRS; Parkinson's disease; Rating scales; Validation

Mesh:

Year:  2017        PMID: 28965872      PMCID: PMC5972376          DOI: 10.1016/j.parkreldis.2017.09.012

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  8 in total

Review 1.  Non-motor symptoms of Parkinson's disease: diagnosis and management.

Authors:  K Ray Chaudhuri; Daniel G Healy; Anthony H V Schapira
Journal:  Lancet Neurol       Date:  2006-03       Impact factor: 44.182

2.  IPMDS-Sponsored Scale Translation Program: Process, Format, and Clinimetric Testing Plan for the MDS-UPDRS and UDysRS.

Authors:  Christopher G Goetz; Glenn T Stebbins; Lu Wang; Nancy R LaPelle; Sheng Luo; Barbara C Tilley
Journal:  Mov Disord Clin Pract       Date:  2014-05-14

3.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

4.  Systematic evaluation of rating scales for impairment and disability in Parkinson's disease.

Authors:  Claudia Ramaker; Johan Marinus; Anne Margarethe Stiggelbout; Bob Johannes Van Hilten
Journal:  Mov Disord       Date:  2002-09       Impact factor: 10.338

Review 5.  The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations.

Authors: 
Journal:  Mov Disord       Date:  2003-07       Impact factor: 10.338

6.  Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Authors:  Pablo Martinez-Martin; Carmen Rodriguez-Blazquez; Mario Alvarez-Sanchez; Tomoko Arakaki; Alberto Bergareche-Yarza; Anabel Chade; Nelida Garretto; Oscar Gershanik; Monica M Kurtis; Juan Carlos Martinez-Castrillo; Amelia Mendoza-Rodriguez; Henry P Moore; Mayela Rodriguez-Violante; Carlos Singer; Barbara C Tilley; Jing Huang; Glenn T Stebbins; Christopher G Goetz
Journal:  J Neurol       Date:  2012-08-05       Impact factor: 4.849

7.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.

Authors:  Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2008-11-15       Impact factor: 10.338

8.  Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.

Authors:  Christopher G Goetz; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Glenn T Stebbins; Matthew B Stern; Barbara C Tilley; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J Van Hilten; Nancy LaPelle
Journal:  Mov Disord       Date:  2007-01       Impact factor: 10.338

  8 in total
  4 in total

1.  The influences of behavioral and psychological interventions on the neurological function and MMSE scores in Parkinson's disease patients.

Authors:  Aimin Luo; Shuming Zhong; Shunkai Lai; Yanbin Jia
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

2.  Validation of the Thai Version of the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale.

Authors:  Priya Jagota; Prachaya Srivanitchapoom; Sitthi Petchrutchatachart; Surat Singmaneesakulchai; Apichart Pisarnpong; Praween Lolekha; Suwanna Setthawatcharawanich; Parnsiri Chairangsaris; Natlada Limotai; Pawut Mekawichai; Pattamon Panyakaew; Onanong Phokaewvarangkul; Jirada Sringean; Yuvadee Pitakpatapee; Nancy LaPelle; Pablo Martinez-Martin; Xuehan Ren; Sheng Luo; Glenn T Stebbins; Christopher G Goetz; Roongroj Bhidayasiri
Journal:  J Mov Disord       Date:  2022-03-16

3.  Compensatory movement strategies differentially affect attention allocation and gait parameters in persons with Parkinson's disease.

Authors:  Galit Yogev-Seligmann; Tal Krasovsky; Michal Kafri
Journal:  Front Hum Neurosci       Date:  2022-08-18       Impact factor: 3.473

4.  Validation Study of the Official Korean Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Authors:  Jinse Park; Seong Beom Koh; Kyum Yil Kwon; Sang Jin Kim; Jae Woo Kim; Joong Seok Kim; Kun Woo Park; Jong Sam Paik; Young H Sohn; Jin Young Ahn; Eungseok Oh; Jinyoung Youn; Ji Young Lee; Phil Hyu Lee; Wooyoung Jang; Han Joon Kim; Beom Seok Jeon; Sun Ju Chung; Jin Whan Cho; Sang Myung Cheon; Suk Yun Kang; Mee Young Park; Seongho Park; Young Eun Huh; Seok Jae Kang; Hee Tae Kim
Journal:  J Clin Neurol       Date:  2020-10       Impact factor: 3.077

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.